The 'reflation' sensation: Emerging markets poised to benefit from vaccine rollout and sustained global recovery

Macro scenarios set to work in sector's favour

Nick Eisinger of Vanguard

Nick Eisinger of Vanguard

In the first part of the year, the vaccine rollout is supporting a robust economic recovery and global central banks continue to operate very loose monetary policy.

This scenario favours the emerging markets (EM) asset class, which is relatively well placed to benefit from the global 'reflation' trade. We are, however, mindful of the impact of higher US Treasury...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space

  • Get ahead of regulatory and technological changes affecting fund management

  • Important and breaking news stories selected by the editors delivered straight to your inbox each day

  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts

  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Emerging markets

Wendy Chen of GAM Investments

China: looking beyond the turbulence

Still ample opportunities

Wendy Chen
clock 01 December 2021 • 4 min read
Richard Knight and Simon Gergel

What's in your stock-ings this year?

May be an ideal time for UK stocks

Simon Gergel and Richard Knight
clock 29 November 2021 • 4 min read
UCITS and AIF assets grow in Q3

Retail investors show 'confidence' in long-term UCITS funds in Q3

H1 marked by “significant” reallocation, says EFAMA

clock 29 November 2021 • 1 min read